MiR-186 Inhibited Migration of NSCLC via Targeting cdc42 and Effecting EMT Process

被引：34
|
作者：
Dong, Ying [1 ]
Jin, Xintian [2 ]
Sun, Zhiqiang [3 ]
Zhao, Yueming [4 ]
Song, Xianjing [5 ]
机构：
[1] Tumor Hosp Jilin Prov, Dept Radiotherapy, Changchun 130021, Peoples R China
[2] Tumor Hosp Jilin Prov, Dept Thorac, Changchun 130021, Peoples R China
[3] Tumor Hosp Jilin Prov, Dept Invas Technol, Changchun 130021, Peoples R China
[4] Tumor Hosp Jilin Prov, Dept Oncol, Changchun 130021, Peoples R China
[5] Jilin Univ, Hosp 2, Dept Cardiol, Changchun 130041, Peoples R China
来源：
MOLECULES AND CELLS | 2017年 / 40卷 / 03期
关键词：
cdc42; EMT; migration; MiR-186; NSCLC; CELL-PROLIFERATION; 3RD-LINE TREATMENT; CANCER; EXPRESSION; MICRORNAS; INVASION; MIR-B-10;
D O I：
10.14348/molcells.2017.2291
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this study, qRT-PCR was employed to identify that miR-186 expression level in NSCLC tissues are highly associated with lymph node metastasis. In addition, through the application of western blotting, luciferase assay and qRT-PCR, it was found that miR-186 targeted 3. UTR of cdc42 mRNA and down-regulated cdc42 protein level in a post-transcriptional manner. Transwell assay indicated that cdc42 partially reversed the effect of miR-186 mimics. Besides, miR-186 was proved to regulate EMT by influencing biomarkers of this process and cell adhesion ability. Thus, miR-186 is a potential target for NSCLC therapy. miR-186 is proposed to be one of tumor-suppressors and may serve as a therapeutic target in NSCLC treatment.
引用
收藏
页码：195 / 201
页数：7
相关论文
共 50 条
  • [41] MiR-132 Suppresses the Migration and Invasion of Lung Cancer Cells via Targeting the EMT Regulator ZEB2
    You, Jiacong
    Li, Yang
    Fang, Nianzhen
    Liu, Bin
    Zu, Lingling
    Chang, Rui
    Li, Xuebing
    Zhou, Qinghua
    PLOS ONE, 2014, 9 (03):
  • [42] Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42
    Fu, Min-gen
    Li, Shuo
    Yu, Ting-ting
    Qian, Li-juan
    Cao, Ri-sheng
    Zhu, Hong
    Xiao, Bin
    Jiao, Chun-hua
    Tang, Na-na
    Ma, Jing-jing
    Hua, Jie
    Zhang, Wei-feng
    Zhang, Hong-jie
    Shi, Rui-hua
    FEBS LETTERS, 2013, 587 (21) : 3471 - 3479
  • [43] Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42
    Turnham, Daniel J.
    Yang, William W.
    Davies, Julia
    Varnava, Athina
    Ridley, Anne J.
    Conlan, R. Steven
    Clarkson, Richard W. E.
    CARCINOGENESIS, 2020, 41 (10) : 1432 - 1443
  • [44] Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1/TCTP/Cdc42 pathway
    Gao, Junying
    Ma, Fengqiu
    Wang, Xingjie
    Li, Guorong
    FOOD & FUNCTION, 2020, 11 (11) : 9573 - 9584
  • [45] Nitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1
    Zhou, Jie
    Dehne, Nathalie
    Bruene, Bernhard
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (06) : 741 - 749
  • [46] Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma
    Wang, Hao-Fan
    Jiang, Jian
    Wu, Jia-Shun
    Zhang, Mei
    Pang, Xin
    Dai, Li
    Tang, Ya-Ling
    Liang, Xin-Hua
    CANCERS, 2022, 14 (17)
  • [47] Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals
    Wang, Kefeng
    Sun, Yin
    Tao, Wei
    Fei, Xiang
    Chang, Chawnshang
    CANCER LETTERS, 2017, 394 : 1 - 12
  • [48] p53-p72-Δ225-331-V31I identified in a cholangiocarcinoma cell line promotes migration and invasiveness via the downregulation of claudin-1 expression and the activation of Cdc42
    Puetkasichonpasutha, Janpen
    Suthiphongchai, Tuangporn
    ONCOLOGY REPORTS, 2021, 45 (01) : 368 - 378
  • [49] miR-497 defect contributes to gastric cancer tumorigenesis and progression via regulating CDC42/ITGB1/FAK/PXN/AKT signaling
    Zhang, Lihui
    Yao, Liwen
    Zhou, Wei
    Tian, Jinping
    Ruan, Banlai
    Lu, Zihua
    Deng, Yunchao
    Li, Qing
    Zeng, Zhi
    Yang, Dongmei
    Shang, Renduo
    Xu, Ming
    Zhang, Mengjiao
    Cheng, Du
    Yang, Yanning
    Ding, Qianshan
    Yu, Honggang
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 25 : 567 - 577
  • [50] Elevated Expression of miR302-367 in Endothelial Cells Inhibits Developmental Angiogenesis via CDC42/CCND1 Mediated Signaling Pathways
    Pi, Jingjiang
    Liu, Jie
    Zhuang, Tao
    Zhang, Lin
    Sun, Huimin
    Chen, Xiaoli
    Zhao, Qian
    Kuang, Yashu
    Peng, Sheng
    Zhou, Xiaohui
    Yu, Zuoren
    Tao, Ting
    Tomlinson, Brian
    Chan, Paul
    Tian, Ying
    Fan, Huimin
    Liu, Zhongmin
    Zheng, Xiangjian
    Morrisey, Edward
    Zhang, Yuzhen
    THERANOSTICS, 2018, 8 (06): : 1511 - 1526
12345